Key TakeawaysA $2 billion fund’s latest 13F shows its three biggest adds in the quarter ended June 30 were Viridian Therapeutics, Travere Therapeutics, and Legend Biotech. Analysts’ average price ...

Support is available after your IgA nephropathy diagnosis. These IgAN resources offer information, financial assistance, community, and updates on new treatments.

Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report third quarter 2026 financial results on Monday, November 2, 2026, after the close of the U.S. financial markets. The Company ...

The F/m Emerald Life Sciences Innovation ETF (LFSC) ranks in the 12th percentile of Morningstar’s US Fund Health category, measured against 154 funds over the ...

Mini futures (ESZ26) are up +0.57%, and December Nasdaq 100 E-Mini futures (NQZ26) are up +0.86% this morning, signaling a ...

Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.

In a report released yesterday, Vamil Divan from Guggenheim reiterated a Buy rating on Merck & Company, with a price target of $170.00. The company’s shares closed yesterday at $141.82. Divan covers ...

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three and nine months ended September ...

Get the detailed balance sheet for Travere Therapeutics, Inc. (TVTX). Up to 10 years of financial statements. Quarterly or ...

A San Antonio singer accused of possessing child pornography is now also the subject of a video that allegedly shows a man ...